WordNet

relating to or occurring in a term or fixed period of time; "terminal examinations"; "terminal payments"
a contact on an electrical device (such as a battery) at which electric current enters or leaves (同)pole
station where transport vehicles load or unload passengers or goods (同)terminus, depot
electronic equipment consisting of a device providing access to a computer; has a keyboard and display
being or situated at an end; "the endmost pillar"; "terminal buds on a branch"; "a terminal station"; "the terminal syllable"
causing or ending in or approaching death; "a terminal patient"; "terminal cancer"
of or relating to or situated at the ends of a delivery route; "freight pickup is a terminal service"; "terminal charges"
urge on; cause to act; "The other children egged the boy on, but he did not want to throw the stone through the window" (同)incite, egg on
a pointed instrument that is used to prod into a state of motion (同)goad
in favor of a proposition, opinion, etc.
an argument in favor of a proposal
in favor of (an action or proposal etc.); "a pro vote"
the 2nd letter of the Roman alphabet (同)b
the blood group whose red cells carry the B antigen (同)type_B, group B
the 14th letter of the Roman alphabet (同)n

PrepTutorEJDIC

『終りの』,末端の / 毎期の,定期の;学期末の / 『死に至る』, / 末端 / (電池の)端子 / (町の中心に近い)空港バス発着場;(一般に,鉄道・バスの)終点,終着駅
突き刺す(つつく)こと / 刺し針,突き棒 / (一般に)刺激 / (先のとがったもので)…‘を'突き刺す,つつく《+『名』+『with』+『名』》 / …‘を'刺激する,呼び起こす;〈人〉‘を'励まして(…を)促す《+『名〈人〉+『to』(『into』)+『名』(do『ing』)》 / (…を)突く,つつく《+『at』+『名』》
=professional
賛成論;賛成票(者) / 賛成して
nitrogenの化学記号

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, Shi V, Bransford T, Takeuchi M, Gong J, Lefkowitz M, Packer M, McMurray JJ; Prospective comparison of ARNI with ARB on Management Of heart failUre with preserved ejectioN fracTion (PARAMOUNT) Investigators.Collaborators (69)Zucchiatti N, Jure H, Milesi R, Kuschnir E, Perna E, Majul C, Llanos J, Grosse A, Hominal M, Oliveira M Jr, Bodanese L, Greco O, Rassi S, Gianetti N, Gupta M, Huynh T, Edelmann F, Reddy P, Gupta JB, Sarna MK, Kumar P, Jagtap P, Khan A, Rao S, Rao M, Kumbla M, Ronchi E, Primo C, Bertoli D, Mos L, Sprovieri M, Senni M, Schizzarotto A, Voors AA, Lenderink T, Den Hartog F, Liem AH, Tjeerdsma G, Pinto Y, Derks A, Ponikowski P, Makowiecka-Ciesla M, Pop CF, Militaru C, Opris C, Militaru C, Stanciulescu G, Konrady A, Shoustov S, Simanenkov V, Kobalava Z, Boitsov S, Lam C, Ding ZP, Gonzalez Juanatey JR, Parreño Lde T, Puig JG, Chivite D, Calvo C, Manzano L, Peña G, Coruña A, Modi M, Leimbach W, Adamson P, Promisloff S, Krueger S, Montgomery B, Colan D.
Lancet.Lancet.2012 Oct 20;380(9851):1387-95. doi: 10.1016/S0140-6736(12)61227-6. Epub 2012 Aug 26.
BACKGROUND: Heart failure with preserved ejection fraction is associated with substantial morbidity and mortality, but effective treatments are lacking. We assessed the efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor (ARNI), in patients with this disorder.ME
PMID 22932717

Cracowski JL, Leuchte HH.SourceClinical Pharmacology Unit, Inserm CIC03, Grenoble University Hospital, Grenoble, France.
The American journal of cardiology.Am J Cardiol.2012 Sep 15;110(6 Suppl):32S-38S. doi: 10.1016/j.amjcard.2012.06.014.
Effective management of patients with pulmonary arterial hypertension (PAH) requires comprehensive prognostic evaluation in order to determine optimal management strategies. Although a number of clinical and hemodynamic parameters linked to PAH prognosis have been identified, some are associated wit
PMID 22921030

N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency

YAMASHITA Teruyo,SEINO Yoshihiko,OGAWA Akio,OGATA Ken-ichi,FUKUSHIMA Masato,TANAKA Keiji,MIZUNO Kyoichi
Journal of cardiology 55(3), 377-383, 2010-05-15
NAID 10027052747

参考1

	心不全の可能性はきわめて低い	心不全の可能性は低いが、可能ならば経過観察	軽度の心不全の可能性があるので精査、経過観察	治療対象となる心不全の可能性有り精査 or 専門医紹介	治療対象となる心不全の可能性高精査 or 専門医紹介
BNP	0～18.4	18.4～40	40～100	100～200	200～
NT-proBNP	0～125		125～400	400～900	900～